Previous research has indicated that gastrointestinal inflammation may play a role in the development of parkinsonian disorders. With this in mind, the authors of a new study recently investigated whether...
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
Previous research has suggested that DAPT with clopidrogel and aspirin may lower the rate of recurrent stroke within the first 3 months following minor ischemic stroke or ischemic attack. In a new study,...
Non-motor symptoms of PD have been shown to be associated with sleep disorders and impaired quality of life. In a recent study, researchers investigated the effects of continuous positive airway pressure...
In addition to traditional medications, Ann Marie Collier, MD, from Moab Regional Hospital in Colorado, says that integrative medication could be added to the treatment regimen. Read more about her session...
In a lively debate, James Johnston MD, JD, and James Burke, MD, discussed whether neuroimaging is appropriate for patients with headache. Read more about their session at AAN’s 2019 Annual Meeting and post...
In a recent study, researchers reviewed the efficacy, safety, and cost-effectiveness of a combination therapy compared with levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson disease. ...
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy. ...
